Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Barbour Named To HOPA Board of Directors

Sally Yowell Barbour, PharmD, BCOP, CPP, FHOPA, director of Oncology Pharmacy Programs and clinical oncology pharmacist at Duke Cancer Institute, was recently appointed to the Hematology/Oncology Pharmacy Association ( HOPA ) Board of Directors where she serves at secretary. “I am honored and...

Strike Out For Sarcoma

Step out on Sunday, Sept. 9, for the 9th Annual Strike Out For Sarcoma 5K and Family Run . The event, hosted by Duke Multidisciplinary Sarcoma Program, takes place WakeMed Soccer Field in Cary, North Carolina. According to the American Cancer Society a sarcoma is a type of cancer that develops from...

Hundreds Attend Supportive Care & Survivorship Days

Hundreds of patients, caregivers, survivors and loved ones attended Duke Cancer Institute’s annual Supportive Care and Survivorship Day held in two locations on two different days — at Duke Raleigh Cancer Center on June 5 and at Duke Cancer Center in Durham on June 6. More than 300 total visitors (...

Clarke To Lead Team DCI At 2018 LUNGe Forward 5K

The Lung Cancer Inititative of North Carolina will host its 12th annual LUNGe Forward 5K on Sunday, Sept. 23, at 12:30 p.m. at Midtown Park at North Hills Mall in Raleigh, North Carolina. Team Duke Cancer Institute will be led this year by Jeffrey Clarke , MD, a medical oncologist specializing in...

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of...

Patient’s Advice: Nourish The Soul     

Nadine Tolman takes a sip of water from a plastic cup that her husband, Fay, has just brought her from the refreshment station. “Remember, you need to stay hydrated,” he says softly, laying his hand on her shoulder, “and don’t forget to eat your lunch.” The gentle gesture from her husband disrupts...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute. The blood tests, dubbed “liquid biopsies”, detect...

LeBlanc And Abernethy Patient-Care Paper Recognized

A journal article by hematologic oncologist, palliative care physician, and associate professor of medicine Thomas LeBlanc, MD , and adjunct professor of medicine Amy Abernethy, MD, PhD , has been recognized as a paper that could " Change the World, One Article At A Time " by Springer Nature...

June Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured in the media and academic journals this month. This list features ASCO coverage, including Susan Halabi, MD; Daniel George, MD; and Andrew Armstrong, MD; and other faculty...

Analysis: Survival Benefit for African-Americans with Advanced Prostate Cancer

Contrary to current perceptions, certain African-American men with advanced prostate cancer have as good a chance of survival as white men and might actually have a small advantage, according to a new analysis of more than 8,000 patients who participated in clinical trials. In a study presented...

Black Patients Show Stronger Response to Hormone Therapy for Prostate Cancer

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers. While median survival was similar for both black and white participants in the study, the findings...

Caregiver and Widow Finds Counseling Support At Duke

Susan Hand, 73, has had it with hospitals and cancer. Her husband Charlie, 79, battled colon cancer, tonsil cancer and unrelated heart trouble during the last year of life. He passed away suddenly last August. At about the same time Hand’s sister’s brain cancer returned, resulting in several...

Pages